Leukotriene B4 - LTB4

Drug Profile

Leukotriene B4 - LTB4

Alternative Names: LTB4

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator LTB4 AB
  • Class Antiretrovirals; Leukotrienes
  • Mechanism of Action Leukotriene B4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Bronchiectasis; HIV-1 infections

Most Recent Events

  • 16 Dec 2016 Biomarkers information updated
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Bronchiectasis in Australia (Inhalation)
  • 31 Aug 2015 No recent reports on development identified - Phase-I for HIV-1 infections in Sweden (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top